+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inhalable"

Asia Pacific Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic Obstructive Pulmonary Disease, and Others), By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic Obstructive Pulmonary Disease, and Others), By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 85 Pages
  • Asia Pacific
From
Europe Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic Obstructive Pulmonary Disease, and Others), By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic Obstructive Pulmonary Disease, and Others), By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 85 Pages
  • Europe
From
North America Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic Obstructive Pulmonary Disease, and Others), By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic Obstructive Pulmonary Disease, and Others), By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 76 Pages
  • North America
From
Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021 - Product Thumbnail Image

Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021

  • Report
  • December 2021
  • 156 Pages
  • Global
From
Inhalable Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Inhalable Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 87 Pages
  • Global
From
Nanotechnology Based Approaches for Tuberculosis Treatment - Product Thumbnail Image

Nanotechnology Based Approaches for Tuberculosis Treatment

  • Book
  • June 2020
Loading Indicator

The Inhalable market within the context of Respiratory Drugs is a rapidly growing sector of the pharmaceutical industry. Inhalable drugs are administered directly to the lungs, allowing for rapid absorption and a more targeted delivery of medication. This type of drug delivery is particularly useful for treating respiratory conditions such as asthma, COPD, and cystic fibrosis. Inhalable drugs are also used to treat acute conditions such as bronchitis and pneumonia. Inhalable drugs are typically administered via a metered-dose inhaler (MDI) or a dry powder inhaler (DPI). MDIs are the most common type of inhaler, and they deliver a measured dose of medication in a pressurized aerosol form. DPIs are a newer type of inhaler, and they deliver a dry powder form of medication. The Inhalable market is highly competitive, with many large pharmaceutical companies offering a variety of inhalable drugs. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Show Less Read more